BIOMERICA, INC. (BMRA) Operating cash flow 2017–2026
BIOMERICA, INC. (BMRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.4MFY2026 · since FY2017: -$722,858 → -$3.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$3.4M | +11.0% |
| FY2025 | -$3.8M | +28.3% |
| FY2024 | -$5.4M | +2.1% |
| FY2023 | -$5.5M | -1042.8% |
| FY2022 | -$479,000 | +90.9% |
| FY2021 | -$5.3M | -22.2% |
| FY2020 | -$4.3M | -91.5% |
| FY2019 | -$2.2M | -91.1% |
| FY2018 | -$1.2M | -62.4% |
| FY2017 | -$722,858 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BMRA financial trends
BMRA RevenueBMRA Net incomeBMRA Net marginBMRA Gross profitBMRA Gross marginBMRA Operating incomeBMRA Operating marginBMRA Free cash flowBMRA Capital expendituresBMRA Return on equityBMRA Stock buybacksBMRA Dividends paidBMRA Total assetsBMRA Total liabilitiesBMRA Shareholders’ equityBMRA overview →